TLV Partners — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
DeepCuredeepcure.aiinNov 2021 · $40M
DeepCure uses AI and machine learning to accelerate drug discovery and development for treating diseases.
AI & Machine LearningBiotechDigital HealthHealthtech
Kfir Schreiber(CEO & Co-Founder)inThrasyvoulos Karydis(CTO & Co-Founder)inJoseph Jacobson(Co-Founder)in
.jpeg.jpg)
Co-investorsIAG Capital PartnersThe E14 Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.